cannabis indica

Índice completo — página 56 de 77

Estudos 5.501 a 5.600 de 7.640, ordenados do mais recente ao mais antigo — nesta página, publicações de 2015. Para buscar por termo ou combinar filtros, use o acervo com busca.

Estudos 5.501 a 5.600

  1. 2015

    Cannabidiol as a Potential Treatment for Anxiety Disorders.

    FavorávelMetanáliseAnsiedadeTEPTTOC
  2. 2015

    Cannabidiol as an Intervention for Addictive Behaviors: A Systematic Review of the Evidence

    FavorávelMetanáliseDependência Química
  3. 2015

    Cannabidiol Exposure During Neuronal Differentiation Sensitizes Cells Against Redox-Active Neurotoxins

    FavorávelEstudo LaboratorialCâncerCâncer — Neuroblastoma
  4. 2015

    Cannabidiol for the Prevention of Graft-versus-Host-Disease after Allogeneic Hematopoietic Cell Transplantation: Results of a Phase II Study

    FavorávelEnsaio ClínicoRejeição de TransplanteDoença do Enxerto contra Hospedeiro
  5. 2015

    Cannabidiol increases survival and promotes rescue of cognitive function in a murine model of cerebral malaria.

    FavorávelEstudo em AnimaisAnsiedadeDisfunção CognitivaDoenças Neurodegenerativas+1
  6. 2015

    Cannabidiol Protects against Doxorubicin-Induced Cardiomyopathy by Modulating Mitochondrial Function and Biogenesis.

    FavorávelEstudo em AnimaisDoenças Cardiovasculares (DCV)Toxicidade Cardíaca
  7. 2015

    Cannabidiol Stimulates Aml-1a-dependent Glial Differentiation And Inhibits Glioma Stem-like Cells Proliferation By Inducing Autophagy In A TRPV2-dependent Manner

    FavorávelEstudo LaboratorialCâncerCâncer — Cérebro
  8. 2015

    Cannabidiol, a Major Non-Psychotropic Cannabis Constituent Enhances Fracture Healing and Stimulates Lysyl Hydroxylase Activity in Osteoblasts.

    FavorávelEstudo em AnimaisOsteoporoseFraturas Ósseas
  9. 2015

    Cannabinoid 2 receptor antagonism reverses central nervous system injury-induced immune deficiency syndrome

    FavorávelEstudo em AnimaisSepseSíndrome do Choque TóxicoCanabinoides Sintéticos AM-x
  10. 2015

    Cannabinoid CB1 Receptor Agonists Do Not Decrease, but may Increase Acoustic Trauma-Induced Tinnitus in Rats

    DesfavorávelEstudo em AnimaisZumbidoTHC:CBD Farmacêutico
  11. 2015

    Cannabinoid hyperemesis syndrome causing prolonged nausea and vomiting in patients with cannabis abuse

    DesfavorávelMetanáliseSíndrome da Hiperêmese Canabinoide
  12. 2015

    Cannabinoid Hyperemesis Syndrome in a 17-Year-Old Adolescent

    DesfavorávelMetanáliseSíndrome da Hiperêmese Canabinoide
  13. 2015

    Cannabinoid Hyperemesis Syndrome: A Case Report and Literature Review

    DesfavorávelMetanáliseSíndrome da Hiperêmese Canabinoide
  14. 2015

    Cannabinoid hyperemesis syndrome: a cause of refractory nausea and vomiting in pregnancy

    DesfavorávelMetanáliseGestaçãoSíndrome da Hiperêmese Canabinoide
  15. 2015

    Cannabinoid hyperemesis syndrome: a guide for the practicing clinician

    DesfavorávelMetanáliseSíndrome da Hiperêmese Canabinoide
  16. 2015

    Cannabinoid Hyperemesis Syndrome: A Paradoxical Cannabis Effect

    DesfavorávelMetanáliseSíndrome da Hiperêmese Canabinoide
  17. 2015

    Cannabinoid hyperemesis syndrome: about 6 cases

    DesfavorávelMetanáliseNáusea e VômitoSíndrome da Hiperêmese Canabinoide
  18. 2015

    Cannabinoid hyperemesis syndrome: an important differential diagnosis of persistent unexplained vomiting

    DesfavorávelMetanáliseSíndrome da Hiperêmese Canabinoide
  19. 2015

    Cannabinoid inhibits HIV-1 Tat-stimulated adhesion of human monocyte-like cells to extracellular matrix proteins.

  20. 2015

    Cannabinoid receptor type 1 agonist ACEA improves motor recovery and protects neurons in ischemic stroke in mice

  21. 2015

    Cannabinoid receptors: Their impact in epidermal differentiation and possible role in treatment of psoriasis

    FavorávelEstudo em AnimaisPsoríase
  22. 2015

    Cannabinoid WIN55, 212-2 induces cell cycle arrest and inhibits the proliferation and migration of human BEL7402 hepatocellular carcinoma cells

  23. 2015

    Cannabinoids and Tremor Induced by Motor-related Disorders: Friend or Foe?

  24. 2015

    Cannabinoids for Medical Use A Systematic Review and Meta-analysis

    FavorávelMetanáliseDorDor — CrônicaInsônia e Distúrbios do Sono+3
  25. 2015

    Cannabinoids for nausea and vomiting in adults with cancer receiving chemotherapy.

    FavorávelMetanáliseNáusea e VômitoNáusea e Vômito por Quimioterapia
  26. 2015

    Cannabinoids for the Treatment of Chronic Non-Cancer Pain: An Updated Systematic Review of Randomized Controlled Trials

    FavorávelMetanálise ClínicaDorDor — Crônica
  27. 2015

    Cannabinoids in experimental stroke: a systematic review and meta-analysis

    FavorávelEstudo em AnimaisAVCAnandamida (AEA)Tetraidrocanabinol (THC)+7
  28. 2015

    Cannabinoids In Late-onset Alzheimer's Disease

    FavorávelMetanáliseDisfunção CognitivaDoença de Alzheimer
  29. 2015

    Cannabinoids In Neurodegenerative Disorders And Stroke/Brain Trauma: From Preclinical Models To Clinical Applications

  30. 2015

    Cannabis Allergy: What do We Know Anno 2015

    DesfavorávelMetanáliseAlergia à Cannabis
  31. 2015

    Cannabis exposure and risk of testicular cancer: a systematic review and meta-analysis

    DesfavorávelMetanáliseCâncerCâncer — Testículo
  32. 2015

    Cannabis hyperemesis syndrome: A case report review of treatment

    DesfavorávelMetanáliseSíndrome da Hiperêmese Canabinoide
  33. 2015

    Cannabis in the Treatment of Dystonia, Dyskinesias, and Tics

  34. 2015

    Cannabis Smoking and Diabetes Mellitus: Results from Meta-Analysis with Eight Independent Replication Sample.

    FavorávelMetanáliseDiabetes
  35. 2015

    Cannabis smoking and lung cancer risk: Pooled analysis in the International Lung Cancer Consortium

    DesfavorávelMetanáliseCâncerCâncer — Pulmão
  36. 2015

    Cannabis use and mania symptoms: a systematic review and meta-analysis

    DesfavorávelMetanálise ClínicaTranstorno Bipolar
  37. 2015

    Cannabis Use and Reduced Risk of Insulin Resistance in HIV-HCV Infected Patients: A Longitudinal Analysis (ANRS CO13 HEPAVIH)

    FavorávelMetanáliseDiabetesSíndrome MetabólicaHIV/AIDS+1
  38. 2015

    Cannabis use in relation to obesity and insulin resistance in the Inuit population.

    FavorávelMetanáliseObesidadeDiabetesSíndrome Metabólica
  39. 2015

    Cannabis withdrawal and sleep: A systematic review of human studies

  40. 2015

    CB1 cannabinoid receptors mediate endochondral skeletal growth attenuation by Δ9-tetrahydrocannabinol

  41. 2015

    Changes in IGF-I, urinary free cortisol and adipokines during dronabinol therapy in anorexia nervosa: Results from a randomised, controlled trial

    FavorávelEnsaio Clínico Duplo-CegoAnorexia (perda de apetite)Anorexia NervosaTHC Farmacêutico
  42. 2015

    Chronic Administration of Δ9-Tetrahydrocannabinol Induces Intestinal Anti-Inflammatory MicroRNA Expression during Acute Simian Immunodeficiency Virus Infection of Rhesus Macaques.

    FavorávelEstudo em AnimaisHIV/AIDSImunodeficiência por TraumaTetraidrocanabinol (THC)
  43. 2015

    Chronic cannabinoid receptor 2 activation reverses paclitaxel neuropathy without tolerance or cannabinoid receptor 1-dependent withdrawal

  44. 2015

    Chronic cannabinoid receptor stimulation selectively prevents motor impairments in a mouse model of Huntington's disease.

    FavorávelEstudo em AnimaisDoença de HuntingtonCanabinoides Sintéticos WIN-x
  45. 2015

    Chronic pelvic pain, quality of life and sexual health of women treated with palmitoylethanolamide and α-lipoic acid

    FavorávelEnsaio ClínicoDorDor — CrônicaQualidade de VidaPalmitoiletanolamida (PEA)
  46. 2015

    Clinical Safety of a High Dose of Phycocyanin-Enriched Aqueous Extract from Arthrospira (Spirulina) platensis: Results from a Randomized, Double-Blind, Placebo-Controlled Study with a Focus on Anticoagulant Activity and Platelet Activation

    FavorávelEnsaio Clínico Duplo-CegoDorInflamaçãoDor — CrônicaFicocianina+5
  47. 2015

    Clinical trials of N-acetylcysteine in psychiatry and neurology: A systematic review

    FavorávelMetanáliseDorDependência QuímicaDependência — Cannabis+17
  48. 2015

    Cognitive Enhancement Therapy in substance misusing schizophrenia: results of an 18-month feasibility trial

    FavorávelEnsaio ClínicoDependência QuímicaDependência — CannabisDisfunção Cognitiva+3
  49. 2015

    Cognitive performance in a placebo-controlled pharmacotherapy trial for youth with marijuana dependence

    DesfavorávelEnsaio Clínico Duplo-CegoDependência QuímicaEfeitos Adversos da CannabisDependência — Cannabis+1
  50. 2015

    Combination of biomarkers for diagnosis of acute kidney injury after cardiopulmonary bypass

  51. 2015

    Comparison of Antispasmodic Effects of Dracocephalum Kotschyi Essential Oil, Limonene and α-Terpineol

    FavorávelEstudo em AnimaisDII — Doença Inflamatória IntestinalDII — Doença de Crohn
  52. 2015

    Comparison of shock wave therapy and nutraceutical composed of Echinacea angustifolia, alpha lipoic acid, conjugated linoleic acid and quercetin (perinerv) in patients with carpal tunnel syndrome

    FavorávelEnsaio ClínicoDorInflamaçãoEstresse OxidativoEquinácea
  53. 2015

    Comprehensive Review of Medicinal Marijuana, Cannabinoids, and Therapeutic Implications in Medicine and Headache: What a Long Strange Trip It's Been …

    FavorávelMetanáliseEnxaqueca
  54. 2015

    Crosstalk between endocannabinoid and immune systems: a potential dysregulation in depression?

  55. 2015

    Cytotoxicity of Endogenous Lipids N-acyl Dopamines and Their Possible Metabolic Derivatives for Human Cancer Cell Lines of Different Histological Origin

  56. 2015

    Deranged endocannabinoid responses to hedonic eating in underweight and recently weight-restored patients with anorexia nervosa

  57. 2015

    Diagnosing and treating cannabinoid hyperemesis

    InconclusivoMetanáliseSíndrome da Hiperêmese Canabinoide
  58. 2015

    Distinct interactions of cannabidiol and morphine in three nociceptive behavioral models in mice

    FavorávelEstudo em AnimaisDorDor — CrônicaDor — Aguda
  59. 2015

    Distinct roles of the endocannabinoids anandamide and 2-arachidonoylglycerol in social behavior and emotionality at different developmental ages in rats

    InconclusivoEstudo em AnimaisAnsiedadeDepressãoAnandamida (AEA)2-Araquidonoilglicerol (2-AG)
  60. 2015

    Does cannabis affect dopaminergic signaling in the human brain? A systematic review of evidence to date

    InconclusivoMetanálise ClínicaPsicoseTetraidrocanabinol (THC)
  61. 2015

    Does marijuana pose risks for chronic airflow obstruction?

    InconclusivoMetanáliseCâncerCâncer — PulmãoDPOC+1
  62. 2015

    Dose-dependent effects of cannabis on the neural correlates of error monitoring in frequent cannabis users

    DesfavorávelEnsaio Clínico Duplo-CegoDependência QuímicaCâncerEfeitos Adversos da CannabisTetraidrocanabinol (THC)+2
  63. 2015

    Drug–drug interaction between clobazam and cannabidiol in children with refractory epilepsy

    FavorávelEnsaio ClínicoEpilepsiaCBD Farmacêutico
  64. 2015

    Dupuytren’s Contracture: Case Study

    FavorávelMetanáliseContratura de Dupuytren
  65. 2015

    Early Phase in the Development of Cannabidiol as a Treatment for Addiction: Opioid Relapse Takes Initial Center Stage.

    FavorávelMetanáliseDependência QuímicaDependência — Opioides
  66. 2015

    Effect of Carvedilol on Serum Heart-type Fatty Acid-binding Protein, Brain Natriuretic Peptide, and Cardiac Function in Patients With Chronic Heart Failure

  67. 2015

    Effect of Non-psychotropic Plant-derived Cannabinoids on Bladder Contractility: Focus on Cannabigerol

    FavorávelEstudo LaboratorialCistiteCanabigerol (CBG)Canabicromeno (CBC)
  68. 2015

    Effects of administration of omega-3 fatty acids with or without vitamin E supplementation on adiponectin gene expression in PBMCs and serum adiponectin and adipocyte fatty acid-binding protein levels in male patients with CAD

  69. 2015

    Effects of bioisosteric fluorine in synthetic cannabinoid designer drugs JWH-018, AM-2201, UR-144, XLR-11, PB-22, 5F-PB-22, APICA, and STS-135

  70. 2015

    Effects of Cannabinoids on T-cell Function and Resistance to Infection.

  71. 2015

    Efficacy and adverse effects of medical marijuana for chronic noncancer pain: Systematic review of randomized controlled trials

    FavorávelMetanálise ClínicaDorDor — CrônicaEsclerose MúltiplaTetraidrocanabinol (THC)+6
  72. 2015

    Efficacy of Inhaled Cannabis on Painful Diabetic Neuropathy.

    FavorávelEnsaio Clínico Duplo-CegoDorDor — Neuropatia Diabética
  73. 2015

    Efficacy of orally administered Silexan in patients with anxiety-related restlessness and disturbed sleep – A randomized, placebo-controlled trial

    FavorávelEnsaio Clínico Duplo-CegoAnsiedadeInsônia e Distúrbios do Sono
  74. 2015

    Efficacy of Silexan in Mixed anxiety-depression--A Randomized, Placebo-Controlled Trial

    FavorávelEnsaio Clínico Duplo-CegoAnsiedadeDepressão
  75. 2015

    Efficacy of ultra-micronized palmitoylethanolamide in canine atopic dermatitis: an open-label multi-centre study

    FavorávelEstudo em AnimaisDorInflamaçãoDor — AgudaPalmitoiletanolamida (PEA)+5
  76. 2015

    Elevated Levels of Endocannabinoids in Chronic Hepatitis C May Modulate Cellular Immune Response and Hepatic Stellate Cell Activation

    InconclusivoEstudo LaboratorialHepatiteAnandamida (AEA)2-Araquidonoilglicerol (2-AG)+2
  77. 2015

    Emerging Therapeutic Targets of Sepsis-Associated Acute Kidney Injury.

    FavorávelMetanáliseInsuficiência RenalAnandamida (AEA)
  78. 2015

    Endocannabinoid Levels in Newborns in Relation to the Mode of Delivery.

  79. 2015

    Endocannabinoid Mechanisms Influencing Nausea.

  80. 2015

    Endocannabinoid Regulation of Neuroendocrine Systems.

    FavorávelMetanáliseEndocanabinoide (não especificado)
  81. 2015

    Endocannabinoid signaling at the periphery: 50 years after THC

    InconclusivoMetanáliseAnandamida (AEA)Endocanabinoide (não especificado)+1
  82. 2015

    Endocannabinoid Signaling Mediates Oxytocin-driven Social Reward

    FavorávelEstudo em AnimaisAutismoAnandamida (AEA)
  83. 2015

    Endocannabinoid system activation may be associated with insulin resistance in women with polycystic ovary syndrome

  84. 2015

    Endocannabinoid-mediated Improvement on a Test of Aversive Memory in a Mouse Model of Fragile X Syndrome

  85. 2015

    Endocannabinoids and Acute Pain Following Total Knee Arthroplasty

  86. 2015

    Endocannabinoids and Neurodegenerative Disorders: Parkinson's Disease, Huntington's Chorea, Alzheimer's Disease, and Others

  87. 2015

    Evaluation of mutagenic and antimicrobial properties of brown propolis essential oil from the Brazilian Cerrado biome

    FavorávelEstudo LaboratorialInfecções BacterianasInfecção por Estafilococos
  88. 2015

    Evaluation of Serum Cytokines Levels and the Role of Cannabidiol Treatment in Animal Model of Asthma

    FavorávelEstudo em AnimaisAsma
  89. 2015

    Evaluation of the anti-inflammatory, anti-catabolic and pro-anabolic effects of E-caryophyllene, myrcene and limonene in a cell model of osteoarthritis

    FavorávelEstudo em AnimaisArtriteArtrite — Osteoartrite
  90. 2015

    Evidence for a Role of Adolescent Endocannabinoid Signaling in Regulating HPA Axis Stress Responsivity and Emotional Behavior Development.

  91. 2015

    Exploiting Cannabinoid-induced Cytotoxic Autophagy To Drive Melanoma Cell Death

    FavorávelEstudo em AnimaisCâncerCâncer — MelanomaCâncer — Metastático
  92. 2015

    FAAH genetic variation enhances fronto-amygdala function in mouse and human

    FavorávelEnsaio ClínicoAnsiedadeTEPTHidrolase de Amidas de Ácidos Graxos (FAAH)
  93. 2015

    Fetal endocannabinoids orchestrate the organization of pancreatic islet microarchitecture.

    FavorávelEstudo em AnimaisDiabetesAnandamida (AEA)2-Araquidonoilglicerol (2-AG)+2
  94. 2015

    Food Liking Enhances the Plasma Response of 2-Arachidonoylglycerol and of Pancreatic Polypeptide upon Modified Sham Feeding in Humans

    FavorávelEnsaio ClínicoPancreatiteAnandamida (AEA)2-Araquidonoilglicerol (2-AG)+2
  95. 2015

    Further human evidence for striatal dopamine release induced by administration of ∆9-tetrahydrocannabinol (THC): selectivity to limbic striatum

  96. 2015

    GABA Deficits Enhance the Psychotomimetic Effects of Δ9-THC

  97. 2015

    Gastroprotective Effect of Alpha-Pinene and Its Correlation With Antiulcerogenic Activity of Essential Oils Obtained From Hyptis Species

    FavorávelEstudo em AnimaisÚlcera Gástrica
  98. 2015

    Genetic moderation of the effects of cannabis: catechol-O-methyltransferase (COMT) affects the impact of Δ9-tetrahydrocannabinol (THC) on working memory performance but not on the occurrence of psychotic experiences

    InconclusivoEnsaio Clínico Duplo-CegoDisfunção CognitivaPsicose
  99. 2015

    Genotoxic and oxidative damage potentials in human lymphocytes after exposure to terpinolene in vitro.

    FavorávelEstudo LaboratorialEstresse Oxidativo
  100. 2015

    Geraniol Ameliorates TNBS-induced Colitis: Involvement of Wnt/β-catenin, p38MAPK, NFκB, and PPARγ Signaling Pathways

    FavorávelEstudo em AnimaisDII — Doença Inflamatória Intestinal